Form 4 for EFX Equifax
Accepted 2025-07-30 00:00:00 ET · period of report 2025-07-28 · accession 0001225208-25-006893 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-07-30 | 2025-07-28 | EFX | Begor Mark W | CEO, Dir | M - OptEx | $191.44 | +28.0K | 191.1K | +17% | +$5.35M |
| DM | 2025-07-30 | 2025-07-28 | EFX | Begor Mark W | CEO, Dir | S - Sale+OE | $241.71 | -48.3K | 190.8K | -20% | -$11.67M |
| D | 2025-07-30 | 2025-07-28 | EFX | Begor Mark W | CEO, Dir | M - OptEx | $0.00 | -28.0K | 28.0K | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-07-28 | M | A | 27,960 | $191.44 | 191,136 | D | — | — | |
| 2 | Common | Common Stock | 2025-07-28 | S | D | 17,731 | $241.87 | 162,713 | D | — | — | (F6) The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $241.41 to $242.40, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. (F3) Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date and 199 shares of common stock purchased pursuant to the Equifax Inc. 2020 Employee Stock Purchase Plan. |
| 3 | Common | Common Stock | 2025-07-28 | S | D | 9,497 | $242.70 | 180,444 | D | — | — | (F5) The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $242.41 to $243.17, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. (F3) Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date and 199 shares of common stock purchased pursuant to the Equifax Inc. 2020 Employee Stock Purchase Plan. |
| 4 | Common | Common Stock | 2025-07-28 | S | D | 831 | $243.90 | 189,941 | D | — | — | (F4) The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $243.47 to $244.44, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. (F3) Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date and 199 shares of common stock purchased pursuant to the Equifax Inc. 2020 Employee Stock Purchase Plan. |
| 5 | Common | Common Stock | 2025-07-28 | S | D | 19,841 | $240.95 | 142,872 | D | — | — | (F7) The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $240.40 to $241.39, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. (F3) Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date and 199 shares of common stock purchased pursuant to the Equifax Inc. 2020 Employee Stock Purchase Plan. |
| 6 | Common | Common Stock | 2025-07-28 | S | D | 364 | $244.95 | 190,772 | D | — | — | (F2) The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $244.72 to $245.33, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. (F3) Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date and 199 shares of common stock purchased pursuant to the Equifax Inc. 2020 Employee Stock Purchase Plan. |
| 7 | Derivative | Stock Option/Right to Buy | 2025-07-28 | M | D | 27,960 | $0.00 | 27,959 | D | $191.44 · — to 2026-02-21 | 27,960 Common Stock | (F8) The option vested in three equal annual increments beginning 2/21/2021. |